Title:
ＧＡＧとそれらのエフェクター分子との相互作用を制御するリガンドおよびその使用
Document Type and Number:
Japanese Patent JP7413286
Kind Code:
B2
Abstract:
The invention relates to new compounds that mimic Glycosaminoglycans and are able to control interaction between Glycosaminoglycans with their effector molecules. The compounds of the invention are peptides and are able to prevent or reduce the binding of at least one effector molecule with at least one glycosaminoglycan. The compounds according to the invention can be used as drug, in particular for the stimulation of the neurogenesis and more generally to treat nervous system related pathologies.
Inventors:
Marais Jean-Maurice
Lavier Solange
marquin rodrigue
prokyants aran
Di Nardo Ariel
testa damian
Lavier Solange
marquin rodrigue
prokyants aran
Di Nardo Ariel
testa damian
Application Number:
JP2020570729A
Publication Date:
January 15, 2024
Filing Date:
June 17, 2019
Export Citation:
Assignee:
Center National de la Cherche Sian Tiffic
Institute National Dra Sante Edra Shersch Medical (Inselm)
SORBONNE UNIVERSITE
Ecole Normal Superior Wool
Institute National Dra Sante Edra Shersch Medical (Inselm)
SORBONNE UNIVERSITE
Ecole Normal Superior Wool
International Classes:
C07K7/08; A61K38/10; A61K38/16; A61P21/00; A61P25/00; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P27/02; A61P27/06; A61P27/16; C07K14/00
Other References:
The Journal of Neuroscience,2012年,Vol.32, No.27,pp.9429-9437
Attorney, Agent or Firm:
Shinichiro Tanaka
▲吉▼田 和彦
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Naoki Yamazaki
▲吉▼田 和彦
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Naoki Yamazaki